Key facts
- This page summarizes Mary Miller's Form 4 filing for Acrivon Therapeutics, Inc. (ACRV).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 26 Oct 2026, 16:03.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Sale
Additional SEC filing notes
Footnote F1
Shares sold automatically to satisfy the mandatory tax withholding requirement upon vesting of restricted stock units.
Footnote F2
The price reported in Column 4 above reflects the weighted average price of 513 shares sold by a broker on October 22, 2026, to satisfy the payment of withholding tax liability of the reporting person.